The benefits of DOX + Rh2 combined treatment may come from: (1) complementary action of Rh2 on cancerous cells to promote cell death pathways and/or inhibit tumor invasion, (2) Rh2-induced activation of immune response to combat cancer; (3) Rh2-induced protection against DOX side effects for healthy cells. The gene discussed is RHAG; the disease is neoplasm.